Trial Profile

Pilot clinical trial of treatment with pioglitazone + metformin + flutamide versus Low-Dose Ethinyl Estradiol + cyproterone acetate as a control, in Adolescents with Ovarian Hyperandrogenism and Hyperinsulinism: Effects on Parameters of Chronic Inflammation, Type 2 Diabetes and cardiovacular risk [Ensayo clinico piloto de tratamiento con Pioglitazona+Flutamida+Metformina a Dosis Bajas versus Etinil-Estradiol + Acetato de Ciproterona como control, en Adolescentes con Hiperandrogenismo Ovarico e Hiperinsulinismo: Efectos sobre Parametros de Inflamacion Cronica, Diabetes Tipo 2 y Riesgo Cardiovacular]

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Aug 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Flutamide (Primary) ; Metformin (Primary) ; Pioglitazone (Primary) ; Ethinylestradiol/cyproterone
Indications Ovarian hyperstimulation syndrome
Focus Pharmacodynamics

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com